Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Technology Stocks : Stock Swap -- Ignore unavailable to you. Want to Upgrade?

To: Andrew Vance who wrote (17093)	4/20/2000 3:48:00 PM
From: Tech Master	Respond to of 17305

Oops, I this posted news to the "Chat" thread! Sorry! Thursday April 20, 2:16 pm Eastern Time Company Press Release Celsion Corporation's Breast Cancer Treatment to be Featured in Television Segment, 'Medical Breakthroughs' The Celsion Segment Will be Distributed to 130 Local Network and Cable News Stations COLUMBIA, Md.--(BW HealthWire)--April 20, 2000-- Celsion Corporation (OTC BB:CELN - news) announced that a medical news production company will distribute a feature news segment on April 26, 2000 regarding Celsion's breast cancer treatment technology. The treatment uses focused microwaves to ablate (kill) tumors without surgery using heat alone. This technology was exclusively licensed from Massachusetts Institute of Technology (``MIT') and was originally developed for the ``Star Wars' defense initiative. The news segment will be distributed throughout the month of May to at least 130 local network and cable news stations. Dr. Robert Gardner at the Center for Breast Surgery, which is a member of Columbia Health Care in Florida, and a breast cancer patient, were interviewed. Dr. Gardner discussed the benefits of microwave technology, as well as the preliminary results of the study. About Celsion: Celsion Corporation is a research and development company dedicated to commercializing medical treatment systems for cancer and other diseases using focused heat technology delivered by patented microwave technology. Celsion has research or commercial associations with leading institutions such as Duke University Medical Center, Harbor UCLA Medical Center, Columbia Hospital (a Columbia/HCA Healthcare member), Montefiore Medical Center, Massachusetts Institute of Technology, the University of California at San Francisco, and Duke University. Forward-looking statements in this release are made pursuant to the ``safe harbor' provisions of the Private Securities Litigation Reform Act of 1995. Investors are cautioned that such forward-looking statements involve risks and uncertainties, including, without limitation, possible changes in cost of materials, expense items, capital expenditures, capital structure, and other financial items; introduction of new products and possible acquisitions of assets or businesses; possible actions by customers, suppliers, competitors, regulatory authorities; and other risks detailed from time to time in the Company's periodic reports filed with the Securities and Exchange Commission. Celsion Corporation 10220-I Old Columbia Road, Columbia MD 21046-1705 T 410.290-5390 F 410.290.5394